Inflammatory Markers in Patients With Active Migraine Headaches
The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.
|Study Design:||Observational Model: Case-Crossover
Time Perspective: Prospective
|Official Title:||Does Migraine As A Partly Inflammatory Disease Increase The Inflammatory Markers Of The Patient When Actively Having a Migraine?|
|Study Start Date:||May 2007|
|Study Completion Date:||February 2009|
A random selection of patients both male and female from a primary care practice with a diagnosis of having migraine headaches will be enrolled. Thirty (30) patients will be recruited mainly from the primary care practice. Recruitment will include males and females aged 21-65. The patients who meet the inclusion criteria will be enrolled. The patients who do not have migraine headaches will also be enrolled and function as controls. Non-migraine patients will meet inclusion criteria 1, 2 and 3 and all of the exclusion criteria.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00471861
|United States, Michigan|
|Westside Family Medical Center, P.C.|
|Kalamazoo, Michigan, United States, 49009|
|Principal Investigator:||Gary E Ruoff, MD||Westside Family Medical Center, P.C.|